陳 炯睿

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Mortality 21%
3. Quarantine 16%
4. Pneumonia 16%
5. Bronchodilator Agents 13%
6. Pandemics 11%
7. Obstructive Lung Diseases 11%
8. Asthma 10%
9. Critical Illness 10%
10. bactericidal permeability increasing protein 8%
11. Respiratory Insufficiency 8%
12. Incentive Reimbursement 8%
13. Pulmonary Surfactant-Associated Protein D 8%
14. Epoxide Hydrolases 7%
15. Confidence Intervals 7%
16. Legionella 7%
17. Chlamydophila pneumoniae 7%
18. Population 7%
19. Coronavirus 6%
20. Area Under Curve 6%
21. Lung 6%
22. Validation Studies 6%
23. Adult Respiratory Distress Syndrome 6%
24. Self-Management 5%
25. Metformin 5%
26. Cohort Studies 5%
27. Airway Obstruction 5%
28. Research Ethics Committees 5%
29. Life Expectancy 5%
30. Basement Membrane 5%
31. Traumatic Brain Injury 5%
32. Logistic Models 5%
33. Artificial Respiration 5%
34. Tobacco Products 5%
35. Odds Ratio 5%
36. Interleukin-4 5%